Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.

Molecular carcinogenesis - 1 Nov 1996

Fuchs-Young R, Howe S, Hale L, Miles R, Walker C

Abstract excerpt

Uterine leiomyoma is the most frequent gynecologic neoplasm in women. By using a panel of cell lines derived from spontaneous Eker rat leiomyomas, we examined the estrogen-responsive phenotype of these tumor cells. Leiomyoma-derived ELT cell lines proliferated in response to estrogen, and estroge...

Topics

Animals
Cell Division
Estradiol
Estrogen Antagonists
Female
Fulvestrant
Leiomyoma
Phenotype
Piperidines
Raloxifene Hydrochloride
Rats
Receptors, Estrogen
Tamoxifen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Tumor Cells, Cultured

Uterine Neoplasms

Source

Identifiers

PMID: 8944075
DOI: 10.1002/(SICI)1098-2744(199611)17:3<151::AID-MC7>3.0.CO;2-I

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8944075-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.PMID 8944075Read ↗

Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.Semantic proximity Read ↗

Uterine leiomyoma in the Eker rat: A unique model for important diseases of womenSemantic proximity Read ↗

Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma CellsSemantic proximity Read ↗

Sex steroidal regulation of uterine leiomyoma growth and apoptosisSemantic proximity Read ↗

Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.Semantic proximity Read ↗

Immortalization of Human Uterine Leiomyoma and Myometrial Cell Lines After Induction of Telomerase Activity: Molecular and Phenotypic CharacteristicsSemantic proximity Read ↗

Gene therapy and uterine leiomyoma: a review.Semantic proximity Read ↗

Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.Semantic proximity Read ↗

Advances in uterine leiomyoma research: the progesterone hypothesis.Semantic proximity Read ↗

The expression of integrins and cadherins in normal human uterus and uterine leiomyomas.Semantic proximity Read ↗

Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor.Semantic proximity Read ↗

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.